Long-Term Efficacy of Megaprosthetic Reconstruction

Recent retrospective data highlights the significance of megaprosthetic reconstruction outcomes over a 30-year period. While limb-salvage surgery has become a standard approach for bone tumors, understanding its lifelong implications is crucial for surgeons. Consequently, long-term follow-up remains essential to manage late-stage complications effectively.

Researchers recently followed 10 patients for over three decades after surgery at two Japanese institutions. This cohort provides rare insight into the durability of these massive implants. Most patients initially presented with osteosarcoma and underwent distal femoral, proximal femoral, or proximal tibial reconstructions at a median age of 22 years.

Assessing Megaprosthetic Reconstruction Outcomes

Although the survival rates for limb salvage are promising, complications remain frequent. Interestingly, 80% of patients experienced complications during the follow-up period. Major revisions occurred in half of the cohort, primarily due to stem fractures and deep infections. Despite these challenges, the median reoperation-free survival was approximately 16.2 years. Furthermore, all patients remained ambulatory at the final follow-up, demonstrating the functional success of the procedure with a median MSTS score of 75.0%.

Surgeons must emphasize the necessity of lifelong monitoring. While patients maintain mobility, the risk of mechanical failure or infection persists indefinitely. Therefore, preoperative counseling should include detailed discussions on potential reoperations. This proactive approach ensures that patients understand the lifelong commitment required after receiving a megaprosthesis.

Frequently Asked Questions

What is the primary risk after megaprosthetic reconstruction?

The study indicates that stem fractures and deep infections are the most common causes for major revision surgery in long-term survivors, occurring even decades after the initial procedure.

Can patients walk normally 30 years after surgery?

Yes, all patients in the study remained ambulatory after three decades, with a median MSTS score of 75.0%, suggesting excellent long-term functional preservation.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

Miyazaki T et al. Outcomes over 30 years after megaprosthetic reconstruction of the lower limb following tumor resection: a retrospective case series of 10 patients. Jpn J Clin Oncol. 2026 Mar 01. doi: undefined. PMID: 41764637.

Jeys LM, et al. The long-term survival of limb-salvage endoprostheses. J Bone Joint Surg Br. 2008;90(2):226-231.

Henderson ER, et al. Failure-mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. Clin Orthop Relat Res. 2011;469(6):1603-1611.